1. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice;Kohl;Nat. Med.,1995
2. Treatment with farnesyl protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) α and TGFα/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis;Nørgaard;Clin. Cancer Res.,1999
3. Tumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase in human tumor xenograft models in wap-ras transgenic mice;Liu;Cancer Res.,1998
4. A phase I and pharmacologic study of the farnesyl protein transferase (FPT) inhibitor SCH 66336 in patients with locally advanced or metastatic cancer;Adjei;Proc. Am. Soc. Clin. Oncol.,1999
5. Matrixmetalloproteinase inhibitors: present achievements and future prospects;Denis;Invest. New Drugs,1997